Clinical Trial Update: T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a HER2-positive T cell–mediated adaptive therapy for digestive-system cancers, including esophageal, gastric, pancreatic, live…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Esophageal Cancer
• Gallbladder Cancer
• Gastric Cancer
• Liver Cancer
• Pancreatic Cancer

Drugs mentioned

• HER2-positive T cell mediated adaptive therapy

Snippet

Sponsor: Yi Miao | Conditions: Esophageal Cancer, Gastric Cancer | Phase 1 | Status: UNKNOWN